823 poster CLINICAL OUTCOME OF PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER TREATED BY INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIATION
Jens O. Brömme(University of Bern), M Schmuecking, Andreas Geretschläger(University of Bern), Jacqueline Vock, Bernd Klaeser(University Hospital of Bern), Trudy Millard Krause, Daniel M. Aebersold(University of Bern), Daniel Rauch(Washington University in St. Louis), Andreas Arnold(University Hospital of Basel), Peter Zbären(University of Bern)
Cited by 0
Related Papers
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
|The Lancet|2015|392
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
|The Lancet Respiratory Medicine|2017|184